Formoterol

Formoterol is a long-acting beta2 adrenergic receptor agonist (LABA) used in the management of asthma and chronic obstructive pulmonary disease (COPD). It is marketed under various brand names including Foradil, Oxeze, and many others.
Pharmacology[edit]
Formoterol works by relaxing the muscles in the walls of the bronchi in the lungs, which helps to open up the airways and make breathing easier. It is a bronchodilator and its effects can last up to 12 hours.
Formoterol is a full agonist at the beta2 adrenergic receptor. This receptor is located on the smooth muscle cells of the bronchi and, when activated, causes the muscle cells to relax and the bronchi to dilate. Formoterol's long duration of action is believed to be due to a high affinity for the lipid bilayer of cell membranes, which allows the drug to remain within the cell and continually stimulate the beta2 receptor.
Clinical Use[edit]
Formoterol is used in the management of asthma and COPD. It is often used in combination with inhaled corticosteroids such as budesonide. This combination has been shown to be more effective in controlling asthma symptoms than either drug alone.
Formoterol is also used in the treatment of exercise-induced bronchospasm. It is taken 15 minutes before exercise to prevent bronchospasm.
Side Effects[edit]
Common side effects of formoterol include palpitations, tremor, and headache. Less common side effects include hypokalemia, hyperglycemia, and insomnia. Rare but serious side effects include paradoxical bronchospasm, cardiac arrhythmias, and anaphylaxis.
Contraindications[edit]
Formoterol is contraindicated in patients with a history of hypersensitivity to the drug or any of its components. It should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
